Cited by 171Adrenal and Paraganglionic TumorsMicroRNA in disease regulationCancer-related molecular mechanisms research

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy

Open access

Patterson, Erin E., Holloway, Alisha K., Weng, Julie, Fojo, Tito, Kebebew, Electron·2011·Cancer

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The authors are interested in identifying molecular markers that can aid in the diagnosis of adrenocortical carcinoma (ACC). The aim of this study was to identify microRNAs (miRNAs or miRs) that are differentially expressed in malignant adrenocortical tumors as compared with benign tumors and assess their potential as diagnostic predictors. METHODS: Differentially expressed miRNAs were identified using microarray profiling of adrenocortical tumors and validated by quantitative real-time RT-PCR. RESULTS: Microarray profiling in benign and primary malignant adrenocortical tumors revealed several significant differences between these histological groups. By using directed quantitative RT-PCR analysis on a subset of these differentially expressed miRNAs, the authors determined that miRs -100, -125b, and -195 were significantly down-regulated, whereas miR-483-5p was significantly up-regulated in malignant as compared with benign tumors. Furthermore, the current study shows that miR-483-5p expression can accurately categorize tumors as benign or malignant. CONCLUSIONS: The authors identified 4 miRNAs that are dysregulated in adrenocortical carcinoma. The high expression of one of these, miR-483-5p, appears to be a defining characteristic of adrenocortical malignancies, and can thus be used to accurately distinguish between benign and malignant adrenocortical tumors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/cncr.25724

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082
Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets
Andersen, C. L., Jensen, J. L., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0496 · Cited by 7,127
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
limma: Linear Models for Microarray Data
Smyth, G. K. (2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0_23 · Cited by 5,796
Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.
Yang, Y., Dudoit, S., Luu, P., Lin, D., Peng, V., Ngai, J., & Speed, T. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.e15 · Cited by 3,722
Normalization of cDNA microarray data
Smyth, G. K., & Speed, T. (2003) · Methods · doi:10.1016/s1046-2023(03)00155-5 · Cited by 1,871
MicroRNAs in Cancer
Garzon, R., Calin, G. A., & Croce, C. M. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.59.053006.104707 · Cited by 1,816

Flagged first, then by citations

Show all 40 references

1 of the 40 references couldn’t be matched to a known paper.

Sorted by citations

Adrenocortical carcinoma
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Integrated genomic characterization of adrenocortical carcinoma
Assié, G., Letouzé, E., Fassnacht, M., Jouinot, A., Luscap, W., Barreau, O., Omeiri, H., Rodriguez, S., Perlemoine, K., René-Corail, F., et al. (2014) · Nature Genetics · doi:10.1038/ng.2953 · Cited by 732
MicroRNA Therapeutics in Cancer: Current Advances and Challenges
Sayed, S. R. E., Cristante, J., Guyon, L., Denis, J., Chabre, O., & Cherradi, N. (2021) · Cancers · doi:10.3390/cancers13112680 · Cited by 217
The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma
Özata, D. M., Caramuta, S., Velázquez‐Fernández, D., Akçakaya, P., Xie, H. Y., Höög, A., Zedenius, J., Bäckdahl, M., Larsson, C., & Lui, W. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0082 · Cited by 199
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients
Chabre, O., Libé, R., Assié, G., Barreau, O., Bertherat, J. Y., BERTAGNA, X. Y., Feige, J., & Cherradi, N. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0051 · Cited by 189
Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes
Díaz‐Prado, S., Cicione, C., Muiños‐López, E., Hermida‐Gómez, T., Oreiro, N., Fernández-López, C., & Blanco, F. J. (2012) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-13-144 · Cited by 182
The Rectal Cancer microRNAome – microRNA Expression in Rectal Cancer and Matched Normal Mucosa
Gaedcke, J., Grade, M., Camps, J., Søkilde, R., Kaczkowski, B., Schetter, A. J., Difilippantonio, M. J., Harris, C. C., Ghadimi, Β. M., Møller, S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0016 · Cited by 179
Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin
Heaton, J. H., Wood, M. A., Kim, A. C., Lima, L. O., Barlaskar, F. M., Almeida, M. Q., Fragoso, M. C. B. V., Kuick, R., Lerario, A. M., Simon, D. P., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.05.026 · Cited by 173
miR-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting RhoGDI1 and ALCAM
Song, Q., Xu, Y., Yang, C., Chen, Z., Jia, C., Chen, J., Zhang, Y., Lai, P., Fan, X., Zhou, X., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2193 · Cited by 165
The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesisPreprint
Liu, M., Roth, A., Yu, M., Morris, R. T., Bersani, F., Rivera, M. N., Lü, J., Shioda, T., Vasudevan, S., Ramaswamy, S., et al. (2013) · Genes & Development · doi:10.1101/gad.224170.113 · Cited by 147
miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways
LIU, Z., Jiang, Z., Huang, J., Huang, S., Li, Y., YU, S., Yu, S., & LIU, X. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2322 · Cited by 140
DNA Methylation Profiling Identifies Global Methylation Differences and Markers of Adrenocortical Tumors
Rechache, N. S., Wang, Y., Stevenson, H. S., Killian, J. K., Edelman, D. C., Merino, M. J., Zhang, L., Nilubol, N., Stratakis, C. A., Meltzer, P. S., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3298 · Cited by 134
Self-citation
Genetics and epigenetics of adrenocortical tumors
Lerário, A. M., Moraitis, A. G., & Hammer, G. D. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.10.028 · Cited by 116
Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor
Warnecke‐Eberz, U., Chon, S., Hölscher, A. H., Drebber, U., & Bollschweiler, E. (2015) · Tumor Biology · doi:10.1007/s13277-015-3112-0 · Cited by 107
Analysis of circulating microRNAs in adrenocortical tumors
Szabó, D. R., Luconi, M., Szabó, P. M., Tóth, M., Szücs, N., Horányi, J., Nagy, Z., Mannelli, M., Patócs, A., Rácz, K., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.148 · Cited by 102
Exploration of Genome-Wide Circulating MicroRNA in Hepatocellular Carcinoma: MiR-483-5p as a Potential Biomarker
Shen, J., Wang, A., Wang, Q., Gurvich, I., Siegel, A. B., Remotti, H. E., & Santella, R. M. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0237 · Cited by 100
MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones
De‐Ugarte, L., Yoskovitz, G., Balcells, S., Güerri‐Fernández, R., Martínez‐Díaz, S., Mellibovsky, L., Urreizti, R., Nogués, X., Grinberg, D., García‐Giralt, N., et al. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0149-2 · Cited by 96
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates
Duregon, E., Volante, M., Giorcelli, J., Terzolo, M., Lalli, E., & Papotti, M. G. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.07.025 · Cited by 90
MiR‐483–5p suppresses the proliferation of glioma cells via directly targeting ERK1
Wang, L., Shi, M., Hou, S., Ding, B., Liu, L., Ji, X., Zhang, J., & Deng, Y. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.035 · Cited by 87
MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors
Patel, D., Boufraqech, M., Jain, M., Zhang, L., He, M., Gesuwan, K., Gulati, N., Nilubol, N., Fojo, T., & Kebebew, E. (2013) · Surgery · doi:10.1016/j.surg.2013.06.022 · Cited by 86
Self-citation
MicroRNAs in the Pineal Gland
Clokie, S. J. H., Lau, P., Kim, H. H., Coon, S. L., & Klein, D. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356733 · Cited by 84
Small regulatory RNAs controlled by genomic imprinting and their contribution to human disease
Girardot, M., Cavaillé, J., & Feil, R. (2012) · Epigenetics · doi:10.4161/epi.22884 · Cited by 90
Genetics of tumors of the adrenal cortex
Bonnet-Serrano, F., & Bertherat, J. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0361 · Cited by 80
microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges
Cherradi, N. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00195 · Cited by 77
Identification of cell-free microRNAs in the urine of patients with prostate cancer
Korzeniewski, N., Tosev, G., Pahernik, S. A., Hadaschik, B. A., Hohenfellner, M., & Duensing, S. M. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.09.015 · Cited by 70
TRIM24 Overexpression Is Common in Locally Advanced Head and Neck Squamous Cell Carcinoma and Correlates with Aggressive Malignant Phenotypes
Cui, Z., Cao, W., Li, J., Song, X., Mao, L., & Chen, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063887 · Cited by 70
MicroRNAs expression profiling of eutopic proliferative endometrium in women with ovarian endometriosis
Laudanski, P., Charkiewicz, R., Kuzmicki, M., Szamatowicz, J., Charkiewicz, A., & Niklinski, J. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-78 · Cited by 70
Role of microRNAs in endocrine cancer metastasis
Lima, C. R., Gomes, C. C., & dos Santos, M. F. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.03.015 · Cited by 69
Adrenocortical carcinoma: Past, present, and future
LaFemina, J., & Brennan, M. F. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23112 · Cited by 67
The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma
Patterson, E., Webb, R., Weisbrod, A. B., Bian, B., He, M., Zhang, L., Holloway, A. K., Krishna, R., Nilubol, N., Pacák, K., et al. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0308 · Cited by 66
Self-citation
Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma
Caramuta, S., Lee, L., Özata, D. M., Akçakaya, P., Xie, H. Y., Höög, A., Zedenius, J., Bäckdahl, M., Larsson, C., & Lui, W. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0098 · Cited by 64
Neuroendocrine tumours: cracking the epigenetic code
Karpathakis, A., Dibra, H. K., & Thirlwell, C. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0338 · Cited by 64
Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors
Perge, P., Butz, H., Pezzani, R., Bancos, I., Nagy, Z., Pálóczi, K., Nyírő, G., Decmann, Á., Pap, E., Luconi, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05777-0 · Cited by 62
MANAGEMENT OF ENDOCRINE DISEASE: Adrenocortical carcinoma: differentiating the good from the poor prognosis tumors
Jouinot, A., & Bertherat, J. Y. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0027 · Cited by 61
Future directions in the diagnosis and medical treatment of adrenocortical carcinoma
Creemers, S. G., Hofland, L. J., Korpershoek, E., Franssen, G. J. H., van Kemenade, F. J., de Herder, W. W., & Feelders, R. A. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0452 · Cited by 61
MiR‐483‐5p and miR‐139‐5p promote aggressiveness by targeting N‐myc downstream‐regulated gene family members in adrenocortical cancer
Agosta, C., Laugier, J., Guyon, L., Denis, J., Bertherat, J. Y., Libé, R., Boisson, B., Stürm, N., Feige, J., Chabre, O., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31363 · Cited by 58
MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations
Duregon, E., Rapa, I., Votta, A., Giorcelli, J., Daffara, F., Terzolo, M., Scagliotti, G. V., Volante, M., & Papotti, M. G. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.04.005 · Cited by 63
Chronic Inflammation and Immunologic-Based Constraints in Malignant Disease
Lowe, D. B., & Storkus, W. J. (2011) · Immunotherapy · doi:10.2217/imt.11.113 · Cited by 58
Insulin growth factor 2 (IGF2) as an emergent target in psychiatric and neurological disorders. Review
Pardo, M., Cheng, Y., Sitbon, Y. H., Lowell, J. A., Grieco, S. F., Worthen, R. J., Desse, S. I., & Barreda-Diaz, A. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.10.012 · Cited by 61
MicroRNA-29a-5p Is a Novel Predictor for Early Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection
Zhu, H., Dong, Q., Sheng, Y., Wei, J., Wang, G., Zhou, H.-J., Ren, N., Jia, H., Ye, Q., & Qin, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052393 · Cited by 56
Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers
Wang, C., Sun, Y., Wu, H., Zhao, D., & Chen, J. (2013) · Histopathology · doi:10.1111/his.12283 · Cited by 55
Prediction Value of miR-483 and miR-214 in Prognosis and Multidrug Resistance of Esophageal Squamous Cell Carcinoma
Zhou, Y., & Hong, L. (2013) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0518 · Cited by 55
MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy
Igaz, P., Igaz, I., Nagy, Z., Nyírő, G., Szabó, P. M., Falus, A., Patócs, A., & Rácz, K. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1752-7 · Cited by 54
ENDOCRINE TUMOURS: The genomics of adrenocortical tumors
Faillot, S., & Assié, G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1118 · Cited by 54
The 'omics' of adrenocortical tumours for personalized medicine
Assié, G., Jouinot, A., & Bertherat, J. Y. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.272 · Cited by 52
Molecular and Therapeutic Advances in the Diagnosis and Management of Malignant Pheochromocytomas and Paragangliomas
Lowery, A., Walsh, S. M., McDermott, E. W. M., & Prichard, R. S. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0410 · Cited by 53
Profiling Plasma MicroRNA in Nasopharyngeal Carcinoma with Deep Sequencing
Wang, H., Yan, L., Shao, Q., Fu, S., Zhang, Z.-C., Ye, W., Zeng, Y.-X., & Shao, J. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.214213 · Cited by 50
Pathobiology and genetics of adrenocortical carcinoma
Pittaway, J. F. H., & Guasti, L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0122 · Cited by 49
Loop-miRs: active microRNAs generated from single-stranded loop regions
Winter, J. J., Link, S., Witzigmann, D., Hildenbrand, C., Previti, C., & Diederichs, S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt251 · Cited by 46
Current management options for recurrent adrenocortical carcinoma
Sidhu, S. B., Glover, A. R., Ip, Zhao, J., Soon, & Robinson (2013) · OncoTargets and Therapy · doi:10.2147/ott.s34956 · Cited by 46
Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy
Koperski, Ł., Kotlarek, M., Świerniak, M., Kolanowska, M., Kubiak, A., Górnicka, B., Jażdżewski, K., & Wójcicka, A. (2017) · Oncotarget · doi:10.18632/oncotarget.16788 · Cited by 47
Specific MicroRNAs Differentiate Adrenocortical Adenomas from Carcinomas and Correlate With Weiss Histopathologic System
Feinmesser, M., Benbassat, C. A., Meiri, E., Benjamin, H., Lebanony, D., Lebenthal, Y., de Vries, L., Drozd, T., & Spector, Y. (2014) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000117 · Cited by 46
The Glucose-Regulated MiR-483-3p Influences Key Signaling Pathways in Cancer
Pepe, F., Visone, R., & Veronese, A. (2018) · Cancers · doi:10.3390/cancers10060181 · Cited by 46
Current Status and Future Targeted Therapy in Adrenocortical Cancer
Alyateem, G., & Nilubol, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.613248 · Cited by 42
Translational applications of microRNAs in cancer, and therapeutic implications
Kwok, G., Zhao, J., Weiss, J., Amaro-Mugridge, N. B., Brahmbhatt, H. N., MacDiarmid, J. A., Robinson, B. G., & Sidhu, S. B. (2017) · Non-coding RNA Research · doi:10.1016/j.ncrna.2017.12.002 · Cited by 43
The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives
Mizdrak, M., Kurir, T. T., & Božić, J. (2021) · Biomedicines · doi:10.3390/biomedicines9020174 · Cited by 44
Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance
Castro, M. A., Corrales, E. P., Molina‐Cerrillo, J., & Alonso‐Gordoa, T. (2021) · Biomedicines · doi:10.3390/biomedicines9030304 · Cited by 43
The Genetics of Adrenocortical Tumors
Espiard, S., & Bertherat, J. Y. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.004 · Cited by 47
Noncoding RNAs in Endocrine Malignancy
Kentwell, J., Gundara, J. S., & Sidhu, S. B. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0458 · Cited by 41
Procyanidins Modulate MicroRNA Expression in Pancreatic Islets
Castell‐Auví, A., Cedó, L., Movassat, J., Portha, B., Sánchez‐Cabo, F., Pallarès, V., Blay, M., Pinent, M., & Ardèvol, A. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf303972f · Cited by 43
Single Nucleotide Polymorphism Microarray Analysis in Cortisol-Secreting Adrenocortical Adenomas Identifies New Candidate Genes and Pathways
Ronchi, C. L., Leich, E., Sbiera, S., Weismann, D., Rosenwald, A., Allolio, B., & Faßnacht, M. (2012) · Neoplasia · doi:10.1593/neo.111758 · Cited by 40
Plasma microRNA profiles of nasopharyngeal carcinoma patients reveal miR-548q and miR-483-5p as potential biomarkers
Zheng, X., Cui, C., Ruan, H.-L., Xue, W., Zhang, S.-D., Hu, Y., Zhou, X., & Jia, W.-H. (2014) · 癌症：英文版 · doi:10.5732/cjc.013.10246 · Cited by 39
MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA Sequencing
Zhang, L., Wei, P., Shen, X., Zhang, Y., Xu, B., Zhou, J., Fan, S., Hao, Z., Shi, H., Zhang, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131336 · Cited by 39
High-Throughput miRNA Sequencing Reveals a Field Effect in Gastric Cancer and Suggests an Epigenetic Network Mechanism
Assumpção, M. B., Moreira, F. C., Hamoy, I. G., de Magalhães, L. L., Vidal, A. F., Pereira, A. L., Burbano, R. M. R., Khayat, A. S., Silva, A., dos Santos, S. E. B., et al. (2015) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s24066 · Cited by 37
Dysregulation of microRNAs in adrenocortical tumors
Singh, P., Soon, P. S. H., Feige, J., Chabre, O., Zhao, J., Cherradi, N., Lalli, E., & Sidhu, S. B. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.041 · Cited by 35
Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples
Gara, S. K., Wang, Y., Patel, D., Liu‐Chittenden, Y., Jain, M., Boufraqech, M., Zhang, L., Meltzer, P. S., & Kebebew, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv908 · Cited by 34
Self-citation
A Unified Framework for the Prediction of Small Molecule–MicroRNA Association Based on Cross-Layer Dependency Inference on Multilayered Networks
Wang, C.-C., & Chen, X. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00667 · Cited by 34
New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer
Salvianti, F., Canu, L., Poli, G., Armignacco, R., Scatena, C., Cantini, G., Franco, A. D., Gelmini, S., Ercolino, T., Pazzagli, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19118 · Cited by 33
MicroRNA Expression Profiling in Adrenal Myelolipoma
Decmann, Á., Perge, P., Nyírő, G., Darvasi, O., Likó, I., Borka, K., Micsík, T., Tóth, Z., Bancos, I., Pezzani, R., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00817 · Cited by 34
miRNAs orchestration of adrenocortical carcinoma - Particular emphasis on diagnosis, progression and drug resistance
El‐Dakroury, W. A., Midan, H. M., Abulsoud, A. I., Elshaer, S. S., El-Husseiny, A. A., Fathi, D., Abdelmaksoud, N. M., Mageed, S. S. A., Elballal, M. S., Zaki, M. B., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154665 · Cited by 31
Advances in translational research of the rare cancer type adrenocortical carcinoma
Ghosh, C., Hu, J., & Kebebew, E. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00623-0 · Cited by 34
Self-citation
CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator ofIGF2imprinting in tumors
Zhang, Y. Q., Hu, J., Wang, H., Cui, J., Gao, S., Hoffman, A. R., & Li, W. (2016) · Oncotarget · doi:10.18632/oncotarget.10918 · Cited by 31
How to Differentiate Benign from Malignant Adrenocortical Tumors?
Viëtor, C. L., Creemers, S. G., van Kemenade, F. J., van Ginhoven, T. M., Hofland, L. J., & Feelders, R. A. (2021) · Cancers · doi:10.3390/cancers13174383 · Cited by 33
The human adrenal cortex: growth control and disorders
Lotfi, C. F. P., Kremer, J. L., Passaia, B. D. S., & Cavalcante, I. P. (2018) · Clinics · doi:10.6061/clinics/2018/e473s · Cited by 31
MicroRNAs in endocrine tumors.
Butz, H., & Patócs, A. (2019) · PubMed Central · Cited by 28
PERK-mediated induction of microRNA-483 disrupts cellular ATP homeostasis during the unfolded protein response
Hiramatsu, N., Chiang, K., Aivati, C., Rodvold, J. J., Lee, J.-M., Han, J., Chea, L., Zanetti, M., Koo, E. H., & Lin, J. H. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008336 · Cited by 28
Medical Approaches in Adrenocortical Carcinoma
Paragliola, R. M., Corsello, A., Locantore, P., Papi, G., Pontecorvi, A., & Corsello, S. M. (2020) · Biomedicines · doi:10.3390/biomedicines8120551 · Cited by 29
Expression of LIN 28 and its regulatory micro RNA s in adult adrenocortical cancer
Faria, A. M., Sbiera, S., Ribeiro, T. C., Soares, I. C., Mariani, B. M. P., Freire, D. S., de Sousa, G. R. V., Lerário, A. M., Ronchi, C. L., Deutschbein, T., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12607 · Cited by 28
The next generation of therapies for adrenocortical cancers
Kirschner, L. S. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.04.001 · Cited by 27
Non-Coding RNAs in Adrenocortical Cancer: From Pathogenesis to Diagnosis
Decmann, Á., Perge, P., Turai, P. I., Patócs, A., & Igaz, P. (2020) · Cancers · doi:10.3390/cancers12020461 · Cited by 27
Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma
Zhang, Z., Ge, S., Wang, X., Yuan, Q., Yan, Q., Ye, H., Che, Y., Lin, Y., Zhang, J., & Liu, P. (2012) · Hepatology International · doi:10.1007/s12072-012-9341-z · Cited by 27
Drug resistance-related microRNAs in esophageal cancer
Hong, L., Han, Y., Lu, Q., Zhang, H., Zhao, Q., Wu, K., & Fan, D. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.711309 · Cited by 25
The role of microRNAs in the pathophysiology of adrenal tumors
Hassan, N., Zhao, J., & Sidhu, S. B. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.011 · Cited by 24
MicroRNA-483-5p Modulates the Expression of Cartilage-Related Genes in Human Chondrocytes through Down-Regulating TGF-β1 Expression
Xu, R., Li, J., Wei, B., Huo, W., & Wang, L. (2017) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.243.41 · Cited by 23
The role of epithelial growth factors and insulin growth factors in the adrenal neoplasms
Angelousi, A. G., Kyriakopoulos, G., Ansari, N. N., Karageorgou, M., & Kassi, E. N. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.05.52 · Cited by 25
miR-375 inhibits the proliferation and invasion of glioblastoma by regulating Wnt5a
Li, G. F., Cheng, Y. Y., Li, B. J., Zhang, C., Zhang, X., Su, J., Wang, C., Chang, L., Zhang, D., Tan, C. L., et al. (2019) · Neoplasma · doi:10.4149/neo_2018_180714n484 · Cited by 22
MicroRNA-205 suppresses the growth of adrenocortical carcinoma SW-13 cells via targeting Bcl-2
Wu, Y., Wang, W., Wei-lie, H., Wen-qing, X., XIAO, G., NIE, Q., Ouyang, K., & Chen, D. (2015) · Oncology Reports · doi:10.3892/or.2015.4295 · Cited by 22
MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas
Ruff, S. M., Ayabe, R. I., Malekzadeh, P., Good, M. L., Wach, M. M., Gonzales, M. K., Tirosh, A., Nilubol, N., Pacák, K., Kebebew, E., et al. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.04.086 · Cited by 22
Self-citation
Immunohistochemical Validation of Overexpressed Genes Identified by Global Expression Microarrays in Adrenocortical Carcinoma Reveals Potential Predictive and Prognostic Biomarkers
Ip, J. C. Y., Pang, T., Glover, A. R., Soon, P. S. H., Zhao, J., Clarke, S. J., Robinson, B. G., Gill, A. J., & Sidhu, S. B. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0392 · Cited by 25
Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma
Jung, S., Nagy, Z., Faßnacht, M., Zambetti, G. P., Weiß, M., Reincke, M., Igaz, P., Beuschlein, F., & Hantel, C. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0249 · Cited by 21
Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis
Armignacco, R., Cantini, G., Canu, L., Poli, G., Ercolino, T., Mannelli, M., & Luconi, M. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0775-y · Cited by 21
Clinical and molecular prognostic factors in adrenocortical carcinoma
Libé, R. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02900-0 · Cited by 21
Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer
Oreglia, M., Sbiera, S., Faßnacht, M., Guyon, L., Denis, J., Cristante, J., Chabre, O., & Cherradi, N. (2020) · Cancers · doi:10.3390/cancers12030724 · Cited by 21
Igf2-derived intronic miR-483 promotes mouse hepatocellular carcinoma cell proliferation
Ma, N., Li, F., Li, D., Hui, Y., Wang, X., Qiao, Y., Zhang, Y., Xiang, Y., Zhou, J., Zhou, L., et al. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1121-x · Cited by 20
Minireview: MIRomics in Endocrinology: A Novel Approach for Modeling Endocrine Diseases
Szabó, P. M., Butz, H., Igaz, P., Rácz, K., Hunyady, L., & Patócs, A. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1220 · Cited by 21
Emerging Therapy for Adrenocortical Carcinoma
Aufforth, R., & Nilubol, N. (2014) · International Journal of Endocrine Oncology · doi:10.2217/ije.14.13 · Cited by 20
Key MicroRNA’s and Their Targetome in Adrenocortical Cancer
Chehade, M., Bullock, M., Glover, A. R., Hutvágner, G., & Sidhu, S. B. (2020) · Cancers · doi:10.3390/cancers12082198 · Cited by 19
mRNA and microRNA expression patterns in adrenocortical cancer.
Zsippai, A., Szabó, D. R., Szabó, P. M., Tömböl, Z., Bendes, M. R., Nagy, Z., Rácz, K., & Igaz, P. (2011) · PubMed Central · Cited by 19
Molecular markers of adrenocortical tumors
Jain, M., Rechache, N. S., & Kebebew, E. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23119 · Cited by 17
Self-citation
Tissue miRNA Combinations for the Differential Diagnosis of Adrenocortical Carcinoma and Adenoma Established by Artificial Intelligence
Turai, P. I., Herold, Z., Nyírő, G., Borka, K., Micsík, T., Tõke, J., Szücs, N., Tóth, M., Patócs, A., & Igaz, P. (2022) · Cancers · doi:10.3390/cancers14040895 · Cited by 19

Authors: Patterson, E. E., Holloway, A. K., Weng, J., Fojo, T., & Kebebew, E.
Affiliations: National Institutes of Health (US)
Gladstone Institutes (US)
University of California, San Francisco (US)
Corresponding author: Kebebew, Electron
ORCID: Holloway, Alisha K.
Weng, Julie
Fojo, Tito
Kebebew, Electron
Venue: Cancer
Publisher: Wiley
Published: 2010-11-08
Volume: 117
Issue: 8
Pages: 1630-1639
ISSN: 0008-543X (ISSN-L)
1097-0142
DOI: 10.1002/cncr.25724
PMC: PMC3051015
OpenAlex: W1989143788
Cited by: 171
References: 40
Citations by year: 2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 14 · 2020: 8 · 2019: 8 · 2018: 14 · 2017: 10 · 2016: 12 · 2015: 20 · 2014: 19 · 2013: 23 · 2012: 22
FWCI: 17.19
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Cancer (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (Z99 CA999999)
Topics: Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords: adrenocortical carcinoma, adrenocortical tumors, miRNA expression profiling, miR-483-5p, miR-100, miR-125b, miR-195, tumor malignancy markers, benign versus malignant differentiation, diagnostic biomarkers
MeSH terms: Adrenal Cortex Neoplasms, Insulin-Like Growth Factor II, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, MicroRNAs, Eukaryotic Initiation Factor-3, Validation Studies as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks